Hepatitis News & Features

More than half of children tested positive for adenovirus, but the public health agency said it is still investigating potential disease causes.

While severe hepatitis with acute liver failure is rare in healthy children and the odds are greatly in your child’s favor should they get hepatitis, your best defense right now against the current, rare cases is information.

Reported cases have occurred in children aged 1 month to 16 years.

Child Hepatitis Cases Detected in Illinois, Canada, Japan April 27, 2022A growing number of severe child hepatitis cases have been detected in the United States and around the world. The cause of the cases is still uncertain.At least three cases were found in Illinois, making it the third state to report such cases.Two cases were reported in suburban Chicago and one in western Illinois, with all the children being under age 10, the Illinois Department of Public Health said in a news release. One child needed a liver transplant.While no cause has been given, all the cases

CDC Issues Alert for Unexplained Hepatitis Cases in Children April 21, 2022The U.S. Centers for Disease Control and Prevention has issued a health advisory urging state and local authorities to watch for cases of hepatitis in children with adenovirus infection.Nine hepatitis cases in which children tested positive for adenovirus have occurred in Alabama since October 2021 among children aged 1-6, with two children needing liver transplants, the CDC said in the advisory issued Thursday.No deaths have been reported. None of the children had COVID or were in poor health, the CDC said.The CDC isn’t saying what

Serious cases of hepatitis in young children, some requiring liver transplants, have been reported in Alabama, the United Kingdom, and Spain, and a cause has yet to be found.

Depression and anxiety are common in people with hepatitis C. Find out how to boost your mental health while you manage your infection.

Learn how support from friends and family, professionals, online communities, and blogs can help you manage life with hepatitis C.

Understand the complications of untreated hepatitis C, and learn why early treatment is so important.

A simpler version of a test for the hepatitis C virus (HCV) may open testing to people in areas where medical care is limited.

Whether or not you tell people about your hepatitis C is your decision. If you want to tell folks about it, but don't know where to start, read on.

The three recipients are: Harvey Alter, a clinical scientist at a U.S. National Institutes of Health blood bank; Charles Rice, of the Washington University in St. Louis; and British-born virologist Michael Houghton.

The last person to become sick with the contagious virus that can cause liver disease was Nov. 5, 2019. Six people have been hospitalized. No deaths have been reported, according to the Food and Drug Administration.

American Airlines would not confirm that one of its flight attendants had hepatitis A or another disease, ABC News reported.

Taking the hepatitis C drugs Mavyret, Zepatier or Vosevi can trigger rare cases of severe liver problems or liver failure in patients who already have moderate-to-severe liver impairment, the FDA warned Wednesday.

Routine screening for hepatitis C -- which can destroy the liver over time -- should occur in all American adults, a key government panel recommended Tuesday.

Although 2016 saw two outbreaks of hepatitis A caused by contaminated food, the main reason for outbreaks has been the living conditions of drug addicts and the homeless.

Almost half of baby boomers in a WebMD reader survey said they haven't been tested for hepatitis C. And as many aren't aware that a cure exists.

Living liver donation carries more risks than a living kidney donation, and it comes with a 0.3% donor risk of death and a 30% risk of complications following an adult-to-adult donation with the larger right liver lobe.

Since June of last year, 214 cases have been reported in Georgia, including 64 last month alone, said Cherie Drenzek, the state epidemiologist, at a Tuesday board meeting of the Georgia Department of Public Health.

The new transplant policy calls for recipients to receive hepatitis C antivirals starting a few hours after leaving the operating room. This strategy could increase the number of potential organs available to patients by 20% to 25%, the lead researcher said.

According to the researchers, this is the first study to show the effectiveness of direct-acting antivirals in patients with chronic hepatitis C infection.

The study suggests that sweeping prevention, screening and treatment efforts could prevent 15.1 million new hepatitis C infections and 1.5 million cirrhosis and liver cancer deaths by 2030.

Since 2002, alcohol-associated liver disease has replaced hepatitis C as the most common reason for U.S. liver transplants.

The CDC has estimated that over 2 million Americans were living with hepatitis C between 2013 and 2016. These latest figures show that about 52 percent of those people were living in nine states: California, Texas, Florida, New York, Pennsylvania, Ohio, Michigan, Tennessee and North Carolina.